Literature DB >> 11482411

Five-year mortality in men and women with atrial fibrillation.

P E Wändell1.   

Abstract

OBJECTIVE: Five-year mortality in men and women with atrial fibrillation (AF).
DESIGN: A follow-up of the medical records of patients with AF registered on September 30, 1993.
SETTING: One community health centre in Stockholm County.
SUBJECTS: 129 patients (76 men and 53 women). MAIN OUTCOME MEASURES: Observed and expected, age- and sex-standardised, 5-year mortality rates. Significant risk factors by multiple logistic regression.
RESULTS: Women had a higher mean age (77.5 vs 72.8 years) and more often suffered from heart failure and hypothyreosis. Five-year mortality rate for men was 30% vs expected 27% in Sweden and 24% in the community; for women it was 43% vs expected 29% (p <0.05) and 23% in the community (p < 0.001), i.e. an excess mortality of 49% and 88%, respectively. Significant factors predicting death by logistic regression among women were: age (odds ratio 1.39, p < 0.001), levothyroxine treatment (odds ratio 27.87, p < 0.05) and diabetes (odds ratio 20.75, p < 0.05).
CONCLUSIONS: AF is related to an excess sex- and age-standardised, 5-year mortality in women but not in men, with levothyroxine treatment as one significant factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11482411     DOI: 10.1080/028134301750235358

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  6 in total

1.  Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiol       Date:  2017-08-30       Impact factor: 2.778

2.  Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.

Authors:  Per Wändell; Axel C Carlsson; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

3.  Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.

Authors:  L Rejnmark; P Vestergaard; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-11-09       Impact factor: 4.507

4.  The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.

Authors:  Ingela Björholt; Stina Andersson; Gunnar H Nilsson; Ingvar Krakau
Journal:  BMC Fam Pract       Date:  2007-02-26       Impact factor: 2.497

5.  Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Sven-Erik Johansson; Matteo Bottai; Kristina Sundquist
Journal:  Diabetol Metab Syndr       Date:  2014-01-07       Impact factor: 3.320

6.  Erroneous computer-based interpretations of atrial fibrillation and atrial flutter in a Swedish primary health care setting.

Authors:  Thomas Lindow; Josefine Kron; Hans Thulesius; Erik Ljungström; Olle Pahlm
Journal:  Scand J Prim Health Care       Date:  2019-11-04       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.